Xeroderma pigmentosum, cockayne syndrome and trichothiodystrophy: Sun sensitivity, DNA repair defects and skin cancer

Genetic Predisposition to Cancer, Second Edition

Volumn , Issue , 2003, Pages 214-231

  Arlett, Colin F ^a   Lehmann, Alan R ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057506870     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (161)

1. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne Syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW (eds) The genetic basis of human cancer. New York: McGraw-Hill, 1998:245–274.
2. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123:241–250.
3. Ramsay CA, Giannelli F. The erythemal action spectrum and deoxyribonucleic acid repair synthesis in xeroderma pigmentosum. Br J Dermatol 1975; 92:49–56.
4. Bridges BA (Chairman), Arlett CF, et al. Solar and ultraviolet radiation. IARC Monograph. Lyon: IARC, 1992.
5. Kraemer KH, Lee MM, Scotto K. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984; 5:511–514.
6. Norris PG, Limb GA, Hamblin AS, et al. Immune function, mutant frequency and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne’s Syndrome and trichothiodystrophy. J Invest Dermatol 1990; 94: 94–100.
7. Gaspari AA, Fleisher TA, Kraemer KH. Impaired interferon production and natural killer cell activation in patients with the skin cancer prone disorder, xeroderma pigmentosum. J Clin Invest 1993; 92:1135–1142.
8. Anstey A, Arlett CF, Cole J, et al. Long term survival and preservation of natural killer cell activity in a xeroderma pigmentosum patient with spontaneous regression and multiple deposits of malignant melanoma. Br J Dermatol 1991; 125:272–278.
9. Turner ML, Moshell AN, Corbett DW, et al. Clearing of melanoma-in-situ with intralesional interferon alpha in a patient with xeroderma pigmentosum. Arch Dermatol 1994; 130:1491–1494.
10. Krutmann J, Bohnert JE, Jung EG. Evidence that DNA damage is a mediate in ultraviolet B radiation-induced inhibition of human gene expression: ultraviolet B radiation effects in intercellular adhesion molecule-1 (ICAM-1) expression. J Invest Dermatol 1994; 102:428–432.
11. Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet 1992; 42:68–84.
12. Lehmann AR, Thompson AF, Harcourt SA, et al. Cockayne syndrome: correlation of clinical features with cellular sensitivity of RNA synthesis to UV-irradiation. J Med Genet 1993; 30:679–682.
13. Itin PH, Pittelkow MR. Trichothiodystrophy: review of sulfurdeficient brittle hair syndromes and association with the ectodermal dysplasias. J Am Acad Dermatol 1990; 20:705–717.
14. Botta E, Nardo T, Broughton BC, et al. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency but gene dosage appears to determine clinical severity. Am J Hum Genet 1998; 63:1036–1048.
15. Gartler SM. Inborn errors of metabolism at the cell culture level. In: Fishbein M (ed.) Second International Conference on Congenital Malformations, New York: International Medical Congress, 1964:94.
16. Cleaver JE. Deficiency in repair replication of DNA in xeroderma pigmentosum. Nature 1968; 218:652–656.
17. Cleaver JE. Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to uv light. J Invest Dermatol 1972; 58:124–128.
18. Lehmann AR, Kirk-Bell S, Arlett CF, et al. Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV-irradiation. Proc Natl Acad Sci USA 1975; 72:219–223.
19. Maher VM, McCormick JJ, Grover P, Sims P. Effect of DNA on the cytotoxicity and mutagenicity of polycyclic hydrocarbon derivatives in normal and xeroderma pigmentosum human fibroblasts. Mutation Res 1977; 43:117–138.
20. Arlett CF, Lowe JE, Harcourt SA, et al. Hypersensitivity of human lymphocytes to UV-B and solar irradiation. Cancer Res 1993; 53:609–614.
21. Hoeijmakers JHJ. Nucleotide excision repair II: from yeast to mammals. Trends Genet 1993; 9:211–217.
22. van Hoffen A, Venema J, Meschini R, et al. Transcriptioncoupled repair removes both cyclobutane pyrimidine dimers and 6-4 photoproducts with equal efficiency and in a sequential way from transcribed DNA in xeroderma pigmentosum group C fibroblasts. EMBO J 1995; 14:360–367.
23. Johnson RT, Squires S. The XP-D complementation group. Insight into xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Mutation Res 1992; 273:97–118.
24. Maher VM, McCormick JJ. Effect of DNA repair on the cytotoxicity and mutagenicity of UV irradiation and of chemical carcinogens in normal and xeroderma pigmentosum cells. In: Yuhas JM, Tennant RW, Regan JB(eds) Biology of radiation carcinogenesis. New York: Raven Press, 1976:129–145.
25. Arlett CF, Harcourt SA. Variation in response to mutagens amongst normal and repair-defective human cells. In: Lawrence CW (ed.) Induced mutagenesis. Molecular mechanisms and their implications for environmental protection. New York: Plenum Press, 1983:249–266.
26. Glover TW, Chang C-C, Trosko JF, Li SS-I. Ultraviolet light induction of diphtheria toxin-resistant mutants in normal and xeroderma pigmentosum human fibroblasts. Proc Natl Acad Sci USA 1979; 76:3982–3986.
27. de Weerd-Kastelein EA, Keijzer W, Rainaldi G, Bootsma D. Induction of sister chromatid exchanges in xeroderma pigmentosum cells after exposure to ultraviolet light. Mutation Res 1977; 45:253–261.
28. Marshall RR, Scott D. The relationship between chromosome damage and cell killing in UV-irradiated normal and xeroderma pigmentosum cells. Mutation Res 1976; 36: 397–400.
29. Dorado G, Steingrimsdottir H, Arlett CF, Lehmann AR. Molecular analysis of UV-induced mutations in a xeroderma pigmentosum cell line. J Mol Biol 1991; 217: 217–222.
30. McGregor WG, Chen R-H, Lukash L, et al. Cell cycle-dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair deficient cells. Mol Cell Biol 1991; 11: 1927–1934.
31. Wang YC, Maher VM, Mitchell DL, McCormick JJ. Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts. Mol Cell Biol 1993; 13: 4276–4283.
32. Bredberg A, Kraemer KH, Seidman MM. Restricted ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum cells. Proc Natl Acad Sci USA 1986; 83: 8273–8277.
33. Cole J, Arlett CF, Norris PG, et al. Elevated hprt mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients. Mutation Res 1992; 273: 171–178.
34. Steingrimsdottir H, Rowley G, Waugh A, et al. Molecular analysis of mutations in the hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors. Mutation Res 1993; 294: 29–41.
35. Scott RJ, Itui P, Kleijer WJ, et al. Xeroderma pigmentosum – Cockayne syndrome complex on two new patients: absence of skin tumors despite severe deficiency of DNA excision repair. J Am Acad Dermatol 1993; 29: 883–889.
36. Vermeulen W, Scott RJ, Potger S, et al. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am J Hum Genet 1994; 54: 191–200.
37. Chang HR, Ishizaki K, Sasaki MS, et al. Somatic mosaicism for DNA repair capacity in fibroblasts derived from a group A xeroderma pigmentosum patient. J Invest Dermatol 1989; 93:460–465.
38. Robbins JH. Defective DNA repair in xeroderma pigmentosum and other neurologic diseases. Curr Opin Neurol Neurosurg 1988; 1: 1077–1083.
39. Kraemer KH. Xeroderma pigmentosum. In: Demis DJ, Dobson RI, McGuire J.(eds) Clinical dermatology, Vol. 4, Hagerstown: Harper and Row, 1980:1–33.
40. Ramsay CA, Coltart TM, Blunt S, et al. Prenatal diagnosis of xeroderma pigmentosum. Lancet 1974; 2:1109–1112.
41. Halley DJJ, Keijzer W, Jaspers NGJ, et al. Prenatal diagnosis of xeroderma pigmentosum (group C) using assays of unscheduled DNA synthesis and postreplication repair. Clinic Genet 1979; 16:137–146.
42. Kraemer KH, DiGiovanna JJ, Moshell AN, et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318:1633–1637.
43. Strong A. Xeroderma pigmentosum variant: prevention of cutaneous neoplasms with etretinate. Retinoids 1989; 17:40–42.
44. Berth-Jones J, Cole J, Lehmann AR, et al. Xeroderma pigmentosum variant: 5 years of tumor suppression by etretinate. J Roy Soc Med 1993; 86:355–356.
45. Tanaka K, Hayakawa H, Sekiguchi M, Okada Y. Specific action of T4 endonuclease V on damaged DNA in xeroderma pigmentosum cells in vivo. Proc Natl Acad Sci USA 1977; 74:2958–2962.
46. Yarosh D, Klein J, O’Connor A, et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 2001; 357:926–929.
47. Wade MH, Chu EHY. Effects of DNA damaging agents on cultured fibroblasts derived from patients with Cockayne syndrome. Mutation Res 1979; 59:49–60.
48. Marshall RR, Arlett CF, Harcourt SA, Broughton BC. Increased sensitivity of cell strains from Cockayne syndrome to sisterchromatid-exchange induction and cell killing by UV light. Mutation Res 1980; 69:107–112.
49. Mayne LV, Lehmann AR. Failure of RNA synthesis to recover after UV-irradiation: an early defect in cells from individuals with Cockayne syndrome and xeroderma pigmentosum. Cancer Res 1982; 42:1473–1478.
50. Lehmann AR, Francis AJ, Giannelli F. Prenatal diagnosis of Cockayne syndrome. Lancet 1985; i:486–488.
51. Stefanini M, Fawcett H, Botta E, et al. Genetic analysis of twenty-two patients with Cockayne syndrome. Hum Genet 1996; 97:418–423.
52. Mallery DL, Tanganelli B, Colella S, et al. Molecular analysis of mutations in the CSB(ERCC6) gene in patients with Cockayne syndrome. Am J Hum Genet 1998; 62:77–85.
53. van Hoffen A, Natarajan AT, Mayne LV, et al. Deficient repair of the transcribed strand of active genes in Cockayne syndrome cells. Nucl Acids Res 1993; 21:5890–5895.
54. Arlett CF, Cole J. Photosensitive human syndromes and cellular defects in DNA repair. In: Jones RR, Wigley T (eds) Ozone depletion: health and environmental consequences. Chichester: Wiley and Sons Ltd, 1989:147–160.
55. Henderson EE, Long WK. Host cell reactivation of UV-and X-ray-damaged herpes simplex virus by Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines. Virology 1981; 115:237–248.
56. Norris PG, Lehmann AR, Cole J, et al. Photosensitivity and lymphocyte hypermutability in Cockayne syndrome. Br J Dermatol 1991; 124:453–460.
57. Broughton BC, Lehmann AR, Harcourt SA, et al. Relationship between pyrimidine dimers, 6-4 photoproducts, repair synthesis and cell survival: studies using cells from patients with trichothiodystrophy. Mutation Res 1990; 235:33–40.
58. Stefanini M, Lagomarsini P, Giliani S, et al. Genetic heterogeneity of the excision repair defect associated with trichothiodystrophy. Carcinogenesis 1993; 14:1101–1105.
59. Weeda G, Eveno E, Donker I, et al. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am J Hum Genet 1997; 60:320–329.
60. Stefanini M, Vermeulen W, Weeda G, et al. A new nucleotide excision repair gene associated with the genetic disorder trichothiodystrophy. Am J Hum Genet 1993; 53:817–821.
61. Cleaver JE, Thompson LH, Richardson AS, States JC. A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum Mutat 1999; 14:9–22.
62. Robins P, Jones CJ, Biggerstaff M, et al. Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA. EMBO J 1991; 10:3913–3921.
63. Sugasawa K, Ng JM, Masutani C, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 1998; 2:223–232.
64. Volker M, Mone MJ, Karmakar P, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 2001; 8:213–224.
65. Miyamoto I, Miura N, Niwa H, et al. Mutational analysis of the structure and function of the xeroderma pigmantosum group A complementing protein. J Biol Chem 1992; 267:12182–12187.
66. Nishigori C, Moriwaki S-I, Takebe H, et al. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan. Arch Dermatol 1994; 130:191–197.
67. de Vries A, van Oostrom CT, Hofhuis FM, et al. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 1995; 377:169–173.
68. Nakane H, Takeuchi S, Yuba S, et al. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 1995; 377:165–168.
69. Robbins JH, Kraemer KH, Lutzner MA, et al. Xeroderma pigmentosum: an inherited disease with sun-sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974; 80:221–248.
70. Weeda G, van Ham RCA, Vermeulen W, et al. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne syndrome. Cell 1990; 62:777–791.
71. Schaeffer L, Roy R, Humbert S, et al. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 1993; 260:58–63.
72. Hoeijmakers JHJ, Egly J-M, Vermeulen W. TFIIH: a key component in multiple DNA transactions. Curr Opin Gen Dev 1996; 6:26–33.
73. Lehmann AR. Dual functions of DNA repair genes: molecular, cellular, and clinical implications. BioEssays 1998; 20:146–155.
74. Bootsma D, Hoeijmakers JHJ. Engagement with transcription. Nature 1993; 363:114–115.
75. Ma L, Siemssen ED, Noteborn M, Van der Eb AJ. The xeroderma pigmentosum group B protein ERCC3 produced in the baculovirus system exhibits DNA helicase activity. Nucl Acids Res 1994; 22:4095–4102.
76. Park E, Guzder SN, Koken MHM, et al. RAD25 (SSL2), the yeast homolog of the human xeroderma pigmentosum group B DNA repair gene, is essential for viability. Proc Natl Acad Sci USA 1992; 89:11416–11420.
77. Schultz P, Fribourg S, Poterszman A, et al. Molecular structure of human TFIIH. Cell 2000; 102:599–607.
78. Tirode F, Busso D, Coin F, Egly JM. Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7. Mol Cell 1999; 3:87–95.
79. Coin F, Bergmann E, Tremeau-Bravard A, Egly JM. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. EMBO J 1999; 18:1357–1366.
80. Vermeulen W, van Vuuren AJ, Chipoulet M, et al. Three unusual repair deficiencies associated with transcription factor BTF2(TFIIH): evidence for the existence of a transcription syndrome. Cold Spring Harb Symp Quant Biol 1994; 59:317–329.
81. Evans E, Moggs JG, Hwang JR, et al. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J 1997; 16:6559–6573.
82. Masutani C, Sugasawa K, Yanagisawa J, et al. Purification and cloning of a nucleotide excision-repair complex involving the xeroderma-pigmentosum group-C protein and a human homolog of yeast RAD23. EMBO J 1994; 13:1831–1843.
83. Mu D, Sancar A. Model for XPC-independent transcriptioncoupled repair of pyrimidine dimers in humans. J Biol Chem 1997; 272:7570–7573.
84. Li L, Bales ES, Peterson CA, Legerski RJ. Characterization of molecular defects in xeroderma pigmentosum group C. Nature Genet 1993; 5:413–417.
85. Chavanne F, Broughton BC, Pietra D, et al. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein and transcript levels. Cancer Res. 2000; 60:1974–1982.
86. Sands AT, Abuin A, Sanchez A, et al. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 1995; 377:162–165.
87. Berg RJ, Ruven HJ, Sands AT, et al. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. J Invest Dermatol 1998; 110:405–409.
88. Cheo DL, Ruven HJ, Meira LB, et al. Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat Res 1997; 374:1–9.
89. Cheo DL, Meira LB, Hammer RE, et al. Synergistic interactions between xpc and p53 mutations in double-mutant mice: neural tube abnormalities and accelerated UV radiationinduced skin cancer. Curr Biol 1996; 6:1691–1694.
90. Dumaz N, Drougar C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA repair deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1993; 90:10529–10533.
91. Giglia G, Dumaz N, Drougard C, et al. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res 1998; 58:4402–4409.
92. Bodak N, Queille S, Avril MF, et al. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc Natl Acad Sci USA 1999; 96:5117–5122.
93. Weber CA, Salazar EP, Stewart SA, Thompson LH. ERCC-2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J 1990; 9:1437–1448.
94. Murray JM, Doe C, Schenk P, et al. Cloning and characterisation of the S. pombe rad15 gene, a homologue to the S. cerevisiae RAD3 and human ERCC2 genes. Nucl Acids Res 1992; 20:2673–2678.
95. Sung P, Prakash L, Matson SW, Prakash S. RAD3 protein of Saccharomyces cerevisiae is a DNA helicase. Proc Natl Acad Sci USA 1987; 84:8951–8955.
96. Sung P, Bailly V, Weber C, et al. Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature 1993; 365:852–855.
97. Schaeffer L, Monocollin V, Roy R, et al. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J 1994; 13:2388–2392.
98. Lehmann AR. Nucleotide excision repair and the link with transcription. Trends Biochem Sci 1995; 20:402–405.
99. Taylor EM, Broughton BC, Botta E, et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA 1997; 94:8658–8663.
100. de Boer J, de Wit J, van Steeg H, et al. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol Cell 1998; 1:981–990.
101. de Boer J, Andressoo JO, de Wit J, et al. Premature ageing in mice deficient in DNA repair and transcription. Science 2002; 296:1276–1279.
102. Berneburg M, Lowe JE, Nardo T, et al. UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome. EMBO J 2000; 19:1157–1166.
103. Sung P, Higgins D, Prakash L, Prakash S. Mutation of lysine-48 to arginine in the yeast RAD3 protein abolishes its ATPase and DNA helicase activities but not the ability to bind ATP. EMBO J 1988; 7:3263–3269.
104. Feaver WJ, Svejstrup JQ, Bardwell L, et al. Dual roles of a multiprotein complex from S. cerevisiae in transcription and DNA repair. Cell 1993; 75:1379–1387.
105. Coin F, Marinoni JC, Rodolfo C, et al. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nature Genet 1998; 20:184–188.
106. Chu G, Chang E. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 1988; 242:564–567.
107. Keeney S, Chang GJ, Linn S. Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J Biol Chem 1993; 268:21293–21300.
108. Nichols AF, Ong P, Linn S. Mutations specific to the xeroderma pigmentosum group E Ddb-phenotype. J Biol Chem 1996; 40:24317–24320.
109. Hwang BJ, Toering S, Francke U, Chu G. p48 Activates a UVdamaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity. Mol Cell Biol 1998; 18:4391–4399.
110. Hwang BJ, Ford JM, Hanawalt PC, Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci USA 1999; 96:424–428.
111. Sijbers AM, de Laat WL, Ariza RR, et al. Xerderma pigmentosum group F caused by a defect in a structurespecific DNA repair endonuclease. Cell 1996; 86:811–822.
112. Matsumura Y, Nishigori C, Yagi T, et al. Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms. Hum Mol Genet 1998; 7:969–974.
113. McWhir J, Selfridge J, Harrison DJ, et al. Mice with DNA repair gene (ercc-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nature Genet 1993; 5:217–223.
114. Weeda G, Donker I, de Wit J, et al. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. Curr Biol 1997; 7:427–439.
115. Fishman-Lobell J, Haber JE. Removal of nonhomologous DNA ends in double-strand break recombination: the role of the yeast ultraviolet repair gene RAD1. Science 1992; 258:480–484.
116. Scherly D, Nouspikel T, Corlet J, et al. Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2. Nature 1993; 363:182–185.
117. MacInnes MA, Dickson JA, Hernandez RR, et al. Human ERCC5 cDNA-cosmid complementation for excision repair and bipartite amino acid domains conserved with RAD proteins of Saccharomyces cerevisiae and Schizosaccharomyces pombe. Mol Cell Biol 1993; 13:6393–6402.
118. O’Donovan A, Scherly D, Clarkson SG, Wood RD. Isolation of active recombinant XPG protein, a human DNA repair endonuclease. J Biol Chem 1994; 269:15965–15968.
119. O’Donovan A, Davies AA, Moggs JG, et al. XPG endonuclease makes the 3_ incision in human DNA nucleotide excision repair. Nature 1994; 371:432–435.
120. Cloud KG, Shen B, Strniste GF, Park MS. XPG protein has a structure-specific endonuclease activity. Mutat Res 1995; 347:55–60.
121. Evans E, Fellows J, Coffer A, Wood RD. Open complex formation around a lesion during nucleotide excision repair provides a structure for cleavage by human XPG protein. EMBO J 1997; 16:625–638.
122. Nouspikel T, Lalle P, Leadon SA, et al. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function. Proc Natl Acad Sci USA 1997; 94:3116–3121.
123. Harada YN, Shiomi N, Koike M, et al. Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene. Mol Cell Biol 1999; 19:2366–2372.
124. Cooper PK, Nouspikel T, Clarkson SG, Leadon SA. Defective transcription-coupled repair of oxidative base damage in Cockayne syndrome patients from XP group G. Science 1997; 275:990–993.
125. Klungland A, Hoss M, Gunz D, et al. Base excision repair of oxidative DNA damage activated by XPG protein. Mol Cell 1999; 3:33–42.
126. Bessho T. Nucleotide excision repair 3´endonuclease XPG stimulates the activity of base excision repair enzyme thymine glycol DNA glycosylase. Nucl Acids Res 1999; 27:979–983.
127. Maher VM, Ouellette LM, Curren RD, McCormick JJ. Frequency of ultraviolet light-induced mutations is higher in xeroderma pigmentosum variant cells than in normal human cells. Nature 1976; 261:593–595.
128. Myhr BC, Turnbull D, DiPaolo JA. Ultraviolet mutagenesis of normal and xeroderma pigmentosum variant human fibroblasts. Mutation Res 1979; 62:341–353.
129. Arlett CF, Harcourt SA, Broughton BC. The influence of caffeine on cell survival in excision-proficient and excisiondeficient xeroderma pigmentosum and normal human cell strains following ultraviolet light irradiation. Mutation Res 1975; 33:341–346.
130. Lawrence CW, Hinkle DC. DNA polymerase zeta and the control of DNA damage induced mutagenesis in eukaryotes. Cancer Surv 1996; 28:21–31.
131. Masutani C, Kusumoto R, Yamada A, et al. The human XPV (xeroderma pigmentosum variant) gene encodes human polymerase h. Nature 1999; 399:700–704.
132. Masutani C, Araki M, Yamada A, et al. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J 1999; 18:3491–3501.
133. Johnson RE, Kondratick CM, Prakash S, Prakash L. RAD30 mutations in the variant form of xeroderma pigmentosum. Science 1999; 285:263–265.
134. Kannouche P, Broughton BC, Volker M, et al. Domain structure, localization and function of DNA polymerase h, defective in xeroderma pigmentosum variant cells. Genes Dev 2001; 15:158–172.
135. Broughton BC, Cordonnier A, Kleijer WJ, et al. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA 2002; 99:815–820.
136. Friedberg EC. Cockayne syndrome–a primary defect in DNA repair, transcription, both or neither? BioEssays 1996; 18:731–738.
137. van Gool AJ, van der Horst GTJ, Citterio E, Hoeijmakers JHJ. Cockayne syndrome: defective repair of transcription. EMBO J 1997; 16:4155–4162.
138. Henning KA, Li L, Iyer N, et al. The Cockayne-syndrome group-A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA-polymerase-II TFIIH. Cell 1995; 82:555–564.
139. Troelstra C, van Gool A, de Wit J, et al. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne syndrome and preferential repair of active genes. Cell 1992; 71:939–953.
140. Eisen JA, Sweder KS, Hanawalt PC. Evolution of the SNF2 family of proteins–subfamilies with distinct sequences and functions. Nucl Acids Res 1995; 23:2715–2723.
141. Selby CP, Sancar A. Human transcription-repair coupling factor CSB/ERCC6 is a DNA-stimulated ATPase but is not a helicase and does not disrupt the ternary transcription complex of stalled RNA polymerase II. J Biol Chem 1997; 272:1885–1890.
142. Pazin MJ, Kadonaga JT. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions. Cell 1997; 88:737–740.
143. Selby CP, Sancar A. Mechanisms of transcription-repair coupling and mutation frequency decline. Microbiol Rev 1994; 58:317–329.
144. van Oosterwijk MF, Versteeg A, Filon R, et al. The sensitivity of Cockayne’s Syndrome cells to DNA-damaging agents is not due to defective transcription-coupled repair of active genes. Mol Cell Biol 1996; 16:4436–4444.
145. Iyer N, Reagan MS, Wu KJ, et al. Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein. Biochemistry 1996; 35:2157–2167.
146. van Gool AJ, Citterio E, Rademakers S, et al. The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in a RNA polymerase II containing complex. EMBO J 1997; 16:5955–5965.
147. Selby CP, Sancar A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc Natl Acad Sci USA 1997; 95:11205–11209.
148. Tantin D, Kansal A, Carey M. Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes. Mol Cell Biol 1997; 17:6803–6814.
149. Tantin D. RNA polymerase II elongation complexes containing the Cockayne syndrome group B protein interact with a molecular complex containing the transcription factor IIH components xeroderma pigmentosum B and p62. J Biol Chem 1998; 273:27794–27799.
150. Bregman DB, Halaban R, van Gool AJ, et al. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc Natl Acad Sci USA 1996; 93:11586–11590.
151. van Gool AJ, Verhage R, Swagemakers SMA, et al. RAD26, the functional S. cerevisiae homolog of the cockayne syndrome B gene ERCC6. EMBO J 1994; 13:5361–5369.
152. Bhatia PK, Verhage RA, Brouwer J, Friedberg EC. Molecular cloning and characterization of Saccharomyces cerevisiae RAD28, the yeast homolog of the human Cockayne Syndrome A (CSA) gene. J Bacteriol 1996; 178:5977–5988.
153. van der Horst GTJ, van Steeg H, Berg RJW, et al. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 1997; 89:425–435.
154. Leadon SA, Cooper PK. Preferential repair of ionizing radiation-induced damage in the transcribed strand of an active human gene is defective in Cockayne syndrome. Proc Natl Acad Sci USA 1993; 90:10499–10503.
155. Le Page F, Kwoh EE, Avrutskaya A, et al. Transcription-coupled repair of 8-oxoguanine:requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell 2000; 101:159–171.
156. Vermeulen W, Bergmann E, Auriol J, et al. Sublimiting concentration of TFIIH transcription/DNA repair factor causes TTD-A trichothiodystrophy disorder. Nature Genet 2000; 26:307–313.
157. Botta E, Nardo T, Lehmann AR, et al. Reduced level of the repair/transcription factor TFIIH in trichothiodystrophy. Hum Mol Genet 2002; 11:2919–2928.
158. Viprakasit V, Gibbons RJ, Broughton BC, et al. Mutations in the general transcription factor TFIIH result in betathalassaemia in individuals with trichothiodystrophy. Hum Mol Genet 2001; 10:2797–2802.
159. Ziegler A, Leffell DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993; 90:4216–4220.
160. Broughton BC, Berneburg M, Fawcett H, et al. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet 2001; 10:2539–2547.
161. Berneburg M, Clingen PH, Harcourt SA, et al. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect. Cancer Res 2000; 60:431–438.